Deomali Herbs Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Ebitda
- Net Worth -4.92%
- Total Assets -1.22%
About Deomali Herbs
Deomali Herbs Private Limited (DHPL) is a Private Limited Indian Non-Government Company incorporated in India on 05 December 2017 (Seven years and one month 26 days old ). Its registered office is in Cuttack, Odisha, India.
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Subrat Swain, Dyanarani, Sundar Rishi, and Three other members serve as directors at the Company.
Company Details
- Location
Cuttack, Odisha, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U74999OR2017PTC027994
- Company No.
027994
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Dec 2017
- Date of AGM
25 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Cuttack
Industry
Who are the key members and board of directors at Deomali Herbs?
Board Members (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Subrat Swain  | Director | 30-Apr-2019 | Current |
| Dyanarani | Director | 03-Dec-2018 | Current |
| Sundar Rishi | Director | 30-Apr-2019 | Current |
| Girish Ranjan | Director | 05-Dec-2017 | Current |
| Eregutu Patra | Director | 05-Dec-2017 | Current |
| Swagatika Nayak | Director | 05-Dec-2017 | Current |
Financial Performance of Deomali Herbs.
Deomali Herbs Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth dipped by a decrease of 4.92%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Deomali Herbs?
Unlock access to Deomali Herbs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charaka Hanf Private LimitedSubrat Swain and Sundar Rishi are mutual person
Cannaaura Biotechnology Private LimitedSubrat Swain and Sundar Rishi are mutual person
- Amet Farm Private Limited
Subrat Swain is a mutual person
- Ayurhemp Private Limited
Subrat Swain and Sundar Rishi are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Deomali Herbs?
Unlock and access historical data on people associated with Deomali Herbs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Deomali Herbs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Deomali Herbs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.